ArticleJMIR pediatrics and parenting2025
Monetary Valuation of Congenital Heart Disease in Indonesia: Economic Modeling Study.
Article in JMIR pediatrics and parenting, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Can development alone save lives? trends and forecasts of congenital heart anomalies-attributable premature mortality in ASEAN.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital heart disease (CHD) constitutes a significant health and economic burden in low- and middle-income countries, including Indonesia. However, its macroeconomic impact across provinces remains poorly quantified.
objectiveThis study aims to estimate the economic burden associated with premature death and disability due to CHD in Indonesia, with a focus on regional and gender disparities.
methodsUsing data from the Global Burden of Disease 2019 study, we assessed the value of lost welfare (VLW) attributable to CHD across all 34 Indonesian provinces. Economic valuation was conducted using 3 approaches: the US Department of Transportation model, a method based on the Organisation for Economic Co-operation and Development, and a national wage-based estimate. Analyses were stratified by sex and derived from both disability-adjusted life years (DALYs) and years of life lost. We examined disparities using two approaches: (1) gender disparity was measured as the relative difference in VLW between males and females, and (2) geographical disparity was quantified using both location quotients (for raw VLW) and a disparity index (for VLW-to-gross domestic product ratios).
resultsThe national CHD-related VLW derived from DALYs was estimated at US $16.83 billion (US Department of Transportation), US $11.41 billion (Organisation for Economic Co-operation and Development), and US $9.03 billion (wage-based). West Java recorded the highest provincial VLW (US $1.60 billion), followed by East Java (US $0.83 billion), North Sumatra (US $0.80 billion), and Central Java (US $0.79 billion), indicating a concentration of burden in populous provinces. In contrast, Yogyakarta (US $0.04 billion), North Kalimantan (US $0.04 billion), and West Papua (US $0.06 billion) had the lowest estimates. In several provinces, male-attributed VLW was more than 150% higher than female VLW, with extreme gaps observed in Riau Islands (281.25%), Aceh (166.10%), and Banten (145.86%). These patterns were consistent across both DALY- and years-of-life-lost-based estimates. Based on the location quotients, provinces such as Papua (2.42), West Sulawesi (2.37), Maluku (1.78), East Nusa Tenggara (1.75), and Central Sulawesi (1.66) bore VLW burdens far greater than their population share. The burden was disproportionately high in several eastern provinces, including East Nusa Tenggara (3.35%), Maluku (2.61%), and West Sulawesi (2.66%).
conclusionsCHD is a macroeconomically manageable burden across most of Indonesia. However, the presence of deep gender disparities and geographically concentrated burdens in eastern and underserved provinces calls for targeted pediatric cardiac health investments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.